Functional Neuroimaging and Genetic Vulnerability to Suicidal Behavior

Suicidal Behavior Clinical Trial

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT02960191
• Other study ID #: 7887
• Status: Terminated
• Phase: N/A
• First received: August 30, 2016
• Last updated: November 7, 2016
• Start date: December 2008
• Est. completion date: March 2012

Study information

• Verified date: November 2016
• Source: University Hospital, Montpellier
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: Agence Nationale de Sécurité du Médicament et des produits de santé
• Study type: Interventional

Clinical Trial Summary

The main objective is to highlight, by functional imaging (MRI) dysfunctional brain regions associated with vulnerability to suicidal behavior.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 95
• Est. completion date: March 2012
• Est. primary completion date: March 2012
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• right-handed

• arm suicidal : Personal history of unipolar depressive disorder or bipolar disorder and having realized in his life at least one suicide attempt

• arm emotional Witnesses : Personal history of unipolar depressive disorder or bipolar disorder and have never done in his life attempted suicide

• arm healthy Witnesses : any current or past personal history of psychiatric disorders of Axis I and have never done in his life attempted suicide

Exclusion Criteria:

• Cons-indications to the use of MRI

• Existence of a past history of head trauma with loss of consciousness or neurological brain disorder or secondary neurological suffering suicidal gesture.

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

• Suicidal Behavior

Intervention

Device:
• Magnetic resonance imaging (MRI)

Locations

Country	Name	City	State
France	University Hospital of Montpellier	Montpellier

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	MRI variations	activation of specific brain areas during the procurement of a test decision	at day 0	No